FBXL21 rs11175654: Genetic Variation and Chronotype
The rs11175654 polymorphism is a common non-coding regulatory variant mapped to the FBXL21 genomic locus. Biological research implicates FBXL21 in the post-translational regulation and degradation of cryptochrome (CRY) proteins within the core molecular circadian clock. Epidemiological and genetic association studies link this variant to subtle statistical shifts in human chronotype, influencing morningness versus eveningness tendencies.
What each genotype means
Typical circadian chronotype
You carry two copies of the common C allele at the FBXL21 locus. In population association studies, this baseline genotype is associated with a typical diurnal preference rather than an allele-driven tendency toward altered morning or evening preference. Because chronotype is complex and polygenic, individual sleep schedules are heavily influenced by environmental cues and many other genetic loci.
Carried by approximately 50% to 55% of individuals in European populations, where it represents the most frequent genotype.
Modest chronotype shift
You carry one copy of the T variant allele at the FBXL21 gene locus. Large-scale genome-wide association studies have linked this regulatory variant to modest shifts in natural chronotype and diurnal preference, potentially influencing the speed of molecular clock cycles. The overall effect on daily sleep timing is subtle, and evidence linking this single locus to significant chronotype alterations remains limited.
Carried by approximately 38% to 40% of people of European ancestry.
Altered chronotype tendency
You carry two copies of the less common T allele near the FBXL21 locus. Circadian rhythm association research links this genotype with a modest shift in diurnal preference compared to the reference genotype, reflecting alterations in molecular CRY protein dynamics. This statistical association is small, and daily habits, light exposure, and many other genetic factors play a much larger role in determining your actual sleep patterns.
Carried by approximately 6% to 8% of individuals of European ancestry.
Genomic Context and the rs11175654 Variant
The single-nucleotide polymorphism rs11175654 is situated in the chromosomal region hosting the FBXL21 locus (historically annotated in human databases as FBXL21 or FBXL21P). This variant represents a single base-pair substitution typically characterized by an exchange between cytosine and thymine alleles. Because rs11175654 does not alter a protein-coding sequence directly, it is classified as a non-coding regulatory variant. Genomic analyses suggest that variants in this region may modulate the transcription efficiency, splicing, or stability of local RNA transcripts. In human genome annotations, the locus has received attention for its evolutionary relationship to related F-box family members, specifically FBXL3. While rs11175654 sits in a regulatory capacity rather than disrupting an essential coding exon, its position allows it to influence downstream regulatory cascades that control rhythmic cellular processes. Variant repositories such as dbSNP catalog rs11175654 among common human polymorphisms, providing a reference framework for ongoing circadian association studies.
Biological Function of the FBXL21 Pathway
The mammalian circadian timing mechanism relies on an autoregulatory transcriptional-translational feedback loop that cycles over roughly twenty-four hours. Core positive transcription factors, including CLOCK and BMAL1, drive the expression of period (PER) and cryptochrome (CRY1 and CRY2) proteins. Once CRY proteins accumulate, they translocate into the nucleus to repress CLOCK:BMAL1 activity. Proper cycling requires periodic clearance of these repressor proteins, a process directed by specialized E3 ubiquitin ligase complexes. FBXL21 (F-box and leucine-rich repeat protein 21) plays an intricate role in this process by counterbalancing its paralog, FBXL3. Studies in mammalian models have demonstrated that FBXL21 operates in a subcellular-compartment-dependent manner, actively regulating the ubiquitination and degradation of CRY proteins in the cytoplasm and nucleus. By fine-tuning the half-life and abundance of CRY, the FBXL21-mediated pathway directly determines the speed and phase of circadian oscillations.
Evidence for Chronotype and Circadian Associations
Genome-wide and candidate-gene association studies have evaluated rs11175654 in connection with natural variations in sleep architecture and behavioral timing, often termed chronotype. Human chronotype captures an individual's intrinsic preference for earlier waking hours (morningness) or later activity patterns (eveningness). The current evidence linking rs11175654 to these traits remains cataloged as limited. While functional cellular assays provide a strong biochemical rationale showing that altering FBXL21 activity shifts circadian period length, population-level association signals for rs11175654 show small effect sizes that fluctuate across cohorts. Chronotype is an intensely polygenic trait influenced by thousands of common variants scattered across the genome, alongside environmental light exposure and social schedules. Consequently, rs11175654 does not serve as a deterministic predictor of whether someone is a night owl or an early bird, but rather represents one minor statistical component of an intricate regulatory network.
Population Distribution and Allele Patterns
Data from large-scale reference databases, including the Genome Aggregation Database (gnomAD) and the 1000 Genomes Project, indicate that rs11175654 is a common polymorphism in global populations. In cohorts of European ancestry, the minor allele frequency is approximately 0.26, indicating that more than a quarter of sequenced chromosomes carry the non-reference allele. While the variant is observed across diverse continental ancestries, precise allele and genotype distributions vary across different demographic groups. Homozygotes for the major allele represent the most common genotype group, while heterozygotes and homozygous minor-allele carriers make up substantial proportions of tested populations. Because the minor allele is maintained at relatively high frequencies without causing severe phenotypic disruption, it is categorized as a benign, normal human sequence variation rather than a pathogenic mutation.
Interpreting Your Genetic Results
Understanding an individual genotype at rs11175654 requires distinguishing between statistical genetic associations and clinical utility. Carrying a particular genotype at this locus does not diagnose a sleep disorder, nor does it guarantee an inflexible morning or evening lifestyle. Clinicians do not use rs11175654 to guide treatment plans or behavioral therapies for circadian rhythm sleep-wake disorders. Personal sleep habits, occupational commitments, artificial light exposure, and age exert far greater influences on day-to-day alertness and sleep quality than any single regulatory SNP. Readers should interpret genotype results at rs11175654 as an educational glimpse into how fundamental biological clocks vary across humans. Anyone struggling with persistent insomnia, excessive daytime sleepiness, or severe circadian misalignment should consult a qualified healthcare provider or sleep specialist for evidence-based evaluation.
How common is this variant?
The rs11175654 variant is common globally, exhibiting a minor allele frequency of approximately 0.26 in European cohorts. Genotype distributions reflect standard Hardy-Weinberg expectations, with major-allele homozygotes representing the majority and minor-allele homozygotes forming a smaller subset.
Frequently asked questions
Does my rs11175654 genotype make me an early bird or a night owl?
No single genetic variant determines whether you are an early riser or an evening person. While rs11175654 is linked to minor statistical shifts in biological timing, thousands of genetic variants and daily lifestyle habits collectively shape your overall chronotype.
Can rs11175654 diagnose a circadian rhythm sleep disorder?
No, rs11175654 is not a clinical diagnostic marker. Circadian sleep-wake disorders are diagnosed by healthcare professionals through comprehensive sleep histories, actigraphy, and clinical evaluations, not common trait-associated SNPs.
What is the biological function of the FBXL21 locus?
The FBXL21 locus encodes a component of an E3 ubiquitin ligase complex that regulates the stability and degradation of cryptochrome (CRY) proteins. By balancing the lifespan of CRY molecules, it helps fine-tune the human molecular clock.
Should I alter my sleep schedule or medications based on this variant?
You should not make changes to your medication regimen or daily health habits based on rs11175654 data. Always discuss any sleep concerns, fatigue, or pharmacological questions directly with a physician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11175654?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29